Position in CADL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$164,800
+$37,851 QoQ
Shares Held
16,000
-38.2% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#90
of 138 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stratos Wealth Advisors, LLC holds $7,912,284 across 9 Biotechnology names. CADL ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,630 | $5,381,150 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
16,585 | $948,993 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
7,022 | $385,788 | |
| 4 | EXEL |
Exelixis, Inc.
|
5,817 | $316,502 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
5,365 | $292,607 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421 | $209,123 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
22,500 | $176,625 | |
| 8 | CADL |
Candel Therapeutics, Inc.
This page
|
16,000 | $164,800 |
All Filings in CADL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,800 | 16,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $126,949 | 25,908 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $129,950 | 23,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $117,300 | 23,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $116,380 | 23,000 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $129,950 | 23,000 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||